Skip to content

Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers

Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01211535
Enrollment
104
Registered
2010-09-29
Start date
2010-09-30
Completion date
2010-11-30
Last updated
2012-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Astigmatism, Refractive Error

Keywords

Soft contact lenses, Multi-purpose Solution

Brief summary

The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.

Interventions

DEVICEOPTI-FREE RepleniSH multipurpose solution

FDA-approved, multipurpose solution used as indicated for cleaning, rinsing, conditioning, disinfecting, and storing study contact lenses on a daily wear basis for 14 days

DEVICEReNu Biotrue multipurpose solution

FDA-approved, multipurpose solution used as indicated for cleaning, disinfecting, daily protein removing, and storing study contact lenses on a daily wear basis for 14 days

Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Currently wearing silicone hydrogel contact lenses on a daily wear basis; * Currently using OPTI-FREE RepleniSH contact lens solution; * Generally healthy; * Normal ocular health; * Willing to follow study procedures and visit schedule; * Sign Informed Consent and privacy document; * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Use of additional lens cleaners; * Known sensitivities to any ingredient in either test article; * Systemic or ocular disease or disorder that would negatively affect the conduct or outcome of the study; * History of ocular surgery/trauma within the last 6 months; * Any topical ocular or systemic antibiotics within 7 days of enrollment continuing throughout the study; * Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollent; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline (Day 0) in Ocular Comfort Rating at Day 14Baseline (Day 0), Day 14Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described, how your eyes feel right now. A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.

Countries

United States

Participant flow

Participants by arm

ArmCount
OPTI-FREE RepleniSH
OPTI-FREE RepleniSH multipurpose solution used with study contact lenses on a daily wear basis for 14 days
52
ReNu Biotrue
ReNu Biotrue multipurpose solution used with study contact lenses on a daily wear basis for 14 days
52
Total104

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01

Baseline characteristics

CharacteristicOPTI-FREE RepleniSHReNu BiotrueTotal
Age Continuous33.3 years
STANDARD_DEVIATION 10.4
35.4 years
STANDARD_DEVIATION 10.96
34.3 years
STANDARD_DEVIATION 10.71
Sex: Female, Male
Female
14 Participants10 Participants24 Participants
Sex: Female, Male
Male
38 Participants42 Participants80 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 520 / 52
serious
Total, serious adverse events
0 / 520 / 52

Outcome results

Primary

Change From Baseline (Day 0) in Ocular Comfort Rating at Day 14

Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described, how your eyes feel right now. A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.

Time frame: Baseline (Day 0), Day 14

Population: All participants who received regimen, satisfied inclusion/exclusion criteria, and completed the 14-day treatment period (per protocol)

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
OPTI-FREE RepleniSHChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Baseline (Day 0)87.40 Units on a scale
OPTI-FREE RepleniSHChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Change from Baseline (Day 0) at Day 14-5.65 Units on a scale
OPTI-FREE RepleniSHChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Day 1481.75 Units on a scale
ReNu BiotrueChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Baseline (Day 0)88.79 Units on a scale
ReNu BiotrueChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Day 1483.18 Units on a scale
ReNu BiotrueChange From Baseline (Day 0) in Ocular Comfort Rating at Day 14Change from Baseline (Day 0) at Day 14-5.61 Units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026